Clinical Trials Browser

Phase 3 × FED × Gastrointestinal × Clear all

NCT03654053 2026-01-07

SACRED

Phase 3 Active not recruiting

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT00004941 2015-03-25

Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease

Phase 3 Completed

Gastrointestinal

Crohn Disease, Gastrointestinal Diseases, Rare Diseases